Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2023-07-27 | 2023-08-12 | 200194 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-08-23 | 2023-09-01 | 202827 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-09-07 | 2024-03-01 | 203834 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2023-10-06 | 2023-11-06 | 206573 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-10-06 | 2023-12-01 | 206576 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-11-10 | 2023-12-08 | 209951 |
| APO-NADOLOL | 40MG | TABLET | Resolved | 2023-11-17 | 2024-01-26 | 210715 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2023-12-01 | 2023-12-22 | 212374 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-01-05 | 2024-01-12 | 215207 |
| APO-OLMESARTAN | 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216714 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-04-12 | 218397 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-02-02 | 2024-03-15 | 218403 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2024-02-23 | 2024-04-05 | 220462 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223064 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Actual shortage | 2024-04-19 | 2024-05-03 | 225796 |
| APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226321 |
| APO-CITALOPRAM | 40MG | TABLET | Actual shortage | 2024-04-26 | 2024-04-26 | 226342 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-CLONAZEPAM | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |